Security key
004890109
Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)
CUSIP: 004890109
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Total 13F shares
- 15,245,438
- Total 13F value
- $109,005,559
- Share change
- +378,770
- SEC-reported price per share
- $7.15
- Number of holders
- 45
- Value change
- +$3,386,877
- Number of buys
- 22
- Number of sells
- 13
- Shares outstanding
- 42,655,924
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
45
Top holders
10
ACRV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Acrivon Therapeutics, Inc. SEC filings
Acrivon Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004890109
Recent filing periods:
Ownership snapshot
Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
11%
PERCEPTIVE ADVISORS LLC
7.1%
Sands Capital Alternatives, LLC
3.9%
CITADEL ADVISORS LLC
3.9%
WELLINGTON MANAGEMENT GROUP LLP
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
11%
|
$23,667,699
4,810,508 shares
|
— | 31 Dec 2023 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
7.1%
|
$14,798,661
3,007,858 shares
|
— | 31 Dec 2023 |
| Sands Capital Alternatives, LLC |
13F
Company
|
3.9%
|
$8,130,817
1,652,605 shares
|
— | 31 Dec 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.9%
|
$8,116,322
1,649,659 shares
|
— | 31 Dec 2023 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.1%
|
$4,369,600
888,130 shares
|
— | 31 Dec 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
1.4%
|
$2,939,548
597,469 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
15,245,438
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
40
Q1 2024 holders
45
Holder diff
5
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend